Streetbeat News

Earnings

NFLX

Netflix's Q3 earnings impressed analysts, leading to increased price targets and positive outlooks. Analysts highlighted strong subscriber growth, revenue guidance, and potential future growth drivers like ad-supported plans and content releases. Netflix's stock rose 10% following the report.

Portfolio Pulse from Chris Katje

October 18, 2024 | 4:32 pm

MSFT

Piper Sandler analysts have adjusted their outlook on Microsoft, maintaining an Overweight rating but lowering the price target from $485 to $470 due to potential 'sloppier than normal' first-quarter results. Despite this, they remain optimistic about Microsoft's AI revenue, expecting it to surpass $10 billion by 2025.

Portfolio Pulse from Erica Kollmann

October 18, 2024 | 4:32 pm

AXP

CVS

DRUG

MGPI

USM

U.S. stocks mostly rose with the Nasdaq gaining 100 points. American Express shares fell 5% after Q3 results, missing revenue estimates but beating EPS. United States Cellular surged 12% on a spectrum sale to Verizon. Bright Minds Biosciences soared 196% after a private placement. MGP Ingredients dropped 26% on weak guidance. CVS Health fell 8% after cutting its Q3 outlook.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 4:29 pm

MMC

Marsh & McLennan (NYSE:MMC) reported better-than-expected Q3 earnings, with EPS of $1.63 beating the consensus of $1.57. The company also announced the acquisition of McGriff Insurance Services. Analysts raised their price targets for MMC following the earnings report.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 4:22 pm

ISRG

Intuitive Surgical (NASDAQ:ISRG) reported strong Q3 earnings, surpassing expectations with a 12% earnings beat and 17% revenue growth. Analysts have raised price targets, citing robust procedure volume growth and the successful uptake of the da Vinci 5 system. The company is well-positioned for continued growth, with plans for a broad launch of the DV5 in mid-2025.

Portfolio Pulse from Priya Nigam

October 18, 2024 | 4:19 pm

MTB

M&T Bank Corporation (NYSE:MTB) reported better-than-expected third-quarter earnings, with EPS of $4.08 beating the consensus estimate of $3.64. Sales also surpassed expectations at $2.332 billion. Following the earnings report, analysts from RBC Capital, Barclays, and Goldman Sachs raised their price targets for MTB. Despite the positive earnings, MTB shares fell 0.5% to $197.98.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 4:14 pm

NOK

Nokia shares are rebounding after a decline due to disappointing Q3 results. The company plans to cut jobs in China and Europe.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 4:11 pm

CVS

ELV

UNH

Elevance Health, CVS Health, and UnitedHealth Group are facing increased medical costs due to the end of a COVID-19 policy that maintained continuous Medicaid enrollment. This has led to lowered profit forecasts and earnings outlooks for these companies.

Portfolio Pulse from Erica Kollmann

October 18, 2024 | 4:09 pm

BX

Blackstone shares are experiencing an upward trend as several analysts have increased their price targets following the company's positive Q3 earnings report.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 4:05 pm

CVS

Health insurance stocks are experiencing a decline due to weak earnings and guidance from several companies in the sector. CVS shares fell further due to a CEO change and weak guidance.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 4:03 pm